Strainsforpains Stock Current Valuation
| EBYH Stock | USD 0.23 0.00 0.00% |
Valuation analysis of Strainsforpains helps investors to measure Strainsforpains' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Strainsforpains' price fluctuation is out of control at this time. Calculation of the real value of Strainsforpains is based on 3 months time horizon. Increasing Strainsforpains' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Strainsforpains is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Strainsforpains Pink Sheet. However, Strainsforpains' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.23 | Real 0.2 | Hype 0.23 | Naive 0.24 |
The intrinsic value of Strainsforpains' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Strainsforpains' stock price.
Estimating the potential upside or downside of Strainsforpains helps investors to forecast how Strainsforpains pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Strainsforpains more accurately as focusing exclusively on Strainsforpains' fundamentals will not take into account other important factors: Strainsforpains Company Current Valuation Analysis
Strainsforpains' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Strainsforpains Current Valuation | 1.56 M |
Most of Strainsforpains' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Strainsforpains is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Strainsforpains has a Current Valuation of 1.56 M. This is 99.99% lower than that of the Oil, Gas & Consumable Fuels sector and significantly higher than that of the Energy industry. The current valuation for all United States stocks is 99.99% higher than that of the company.
Strainsforpains Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Strainsforpains' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Strainsforpains could also be used in its relative valuation, which is a method of valuing Strainsforpains by comparing valuation metrics of similar companies.Strainsforpains is currently under evaluation in current valuation category among its peers.
Strainsforpains Fundamentals
| Current Valuation | 1.56 M | |||
| Price To Earning | (0.87) X | |||
| Net Income | (66.08 K) | |||
| Cash And Equivalents | 2.29 K | |||
| Total Debt | 1.81 M | |||
| Book Value Per Share | (2.94) X | |||
| Cash Flow From Operations | (66.08 K) | |||
| Earnings Per Share | (0.23) X | |||
| Beta | 1.23 | |||
| Market Capitalization | 1.78 M | |||
| Total Asset | 5.04 K | |||
| Retained Earnings | (1.38 M) | |||
| Working Capital | (1.3 M) | |||
| Current Asset | 35 K | |||
| Current Liabilities | 1.34 M | |||
| Annual Yield | 0.04 % | |||
| Net Asset | 5.04 K |
About Strainsforpains Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Strainsforpains's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Strainsforpains using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Strainsforpains based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Strainsforpains Pink Sheet
Strainsforpains financial ratios help investors to determine whether Strainsforpains Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Strainsforpains with respect to the benefits of owning Strainsforpains security.